Week In Review: Novartis In $1 Billion Deal For DTx Pharma

Novartis signed a $1 billion agreement to acquire DTx Pharma, a preclinical San-Diego company developing siRNA therapies for neuroscience indications. Meanwhile, Zhuhai Biotheus formed a far-reaching research/license collaboration with BioNTech SE.